YBX1 and intrahepatic cholangiocarcinoma: Surprisingly, strong knock-down of YB-1 (qPCR >95%, resulting in undetectable levels of YB-1 in ICC) reversed the effect on transduction efficiency (Fig 4A, 4B and 4C and S5A and S5B Fig).